相似文献
1
Genetic counselors: translating genomic science into clinical practice.
J Clin Invest. 2003 Nov;112(9):1274-9. doi: 10.1172/JCI20113.
2
Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO.
J Natl Cancer Inst. 2002 Jun 5;94(11):844-51. doi: 10.1093/jnci/94.11.844.
3
Intellectual property. In a flurry of metaphors, justices debate a limit on gene patents.
Science. 2013 Apr 26;340(6131):421. doi: 10.1126/science.340.6131.421.
4
Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.
Fam Cancer. 2016 Oct;15(4):529-39. doi: 10.1007/s10689-016-9900-x.
5
Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
Genet Test. 2002 Summer;6(2):75-8. doi: 10.1089/10906570260199311.
6
Pretest genetic counseling informs patients with BRCA mutation.
Cancer. 2012 Dec 15;118(24):6017. doi: 10.1002/cncr.27922.
7
NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer.
J Genet Couns. 2013 Apr;22(2):155-63. doi: 10.1007/s10897-012-9547-1. Epub 2012 Nov 28.
8
Hereditary breast and ovarian cancers.
JAAPA. 2008 May;21(5):18, 21. doi: 10.1097/01720610-200805000-00008.
9
Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Cancer Invest. 2003;21(4):588-623. doi: 10.1081/cnv-120022380.
10
Counseling the at risk patient in the BRCA1 and BRCA2 Era.
Obstet Gynecol Clin North Am. 2002 Jun;29(2):341-66, vii. doi: 10.1016/s0889-8545(01)00004-3.
引用本文的文献
1
Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies.
Int J Mol Sci. 2023 Apr 19;24(8):7481. doi: 10.3390/ijms24087481.
2
Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
Eur J Hum Genet. 2023 Jun;31(6):703-711. doi: 10.1038/s41431-023-01311-1. Epub 2023 Mar 20.
3
Australasian Genetic Counselors' Perceptions of Their Role in Supporting Clients' Behavior Change.
J Pers Med. 2022 Dec 23;13(1):30. doi: 10.3390/jpm13010030.
4
Rapid clinical exome sequencing in a pediatric ICU: Genetic counselor impacts and challenges.
J Genet Couns. 2019 Apr;28(2):283-291. doi: 10.1002/jgc4.1116.
5
Genetic counselors' scope of practice and challenges in genetic counseling services in Saudi Arabia.
Int J Pediatr Adolesc Med. 2016 Mar;3(1):1-6. doi: 10.1016/j.ijpam.2015.12.002. Epub 2016 Jan 28.
6
Genetic Counselors in Startup Companies: Redefining the Genetic Counselor Role.
J Genet Couns. 2016 Aug;25(4):649-57. doi: 10.1007/s10897-015-9923-8. Epub 2016 Jan 23.
7
To worry or not to worry: breast cancer genetic counseling communication with low-income Latina immigrants.
J Community Genet. 2015 Jan;6(1):63-76. doi: 10.1007/s12687-014-0202-4. Epub 2014 Aug 23.
8
Patient outcomes associated with group and individual genetic counseling formats.
Fam Cancer. 2012 Mar;11(1):97-106. doi: 10.1007/s10689-011-9486-2.
9
Genetic counseling of adults with Williams syndrome: a first study.
Am J Med Genet C Semin Med Genet. 2010 May 15;154C(2):307-15. doi: 10.1002/ajmg.c.30264.
10
Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
J Mol Diagn. 2008 Sep;10(5):383-95. doi: 10.2353/jmoldx.2008.070161. Epub 2008 Aug 7.
本文引用的文献
1
Back to the Future of Genetic Counseling: Commentary on "Psychosocial Genetic Counseling in the Post-Nondirective Era".
J Genet Couns. 2003 Jun;12(3):213-7. doi: 10.1023/A:1023280118962.
2
Genetic Counseling-Stress, Coping, and the Empowerment Perspective.
J Genet Couns. 1999 Dec;8(6):345-57. doi: 10.1023/A:1022919325772.
3
The need for developing standardized family pedigree nomenclature.
J Genet Couns. 1993 Dec;2(4):261-73. doi: 10.1007/BF00961575.
4
Psychosocial genetic counseling in the post-nondirective era: a point of view.
J Genet Couns. 2003 Jun;12(3):199-211. doi: 10.1023/a:1023234802124.
5
Gene patents and the public good.
Nature. 2003 May 15;423(6937):207. doi: 10.1038/423207b.
6
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
Am J Hum Genet. 2003 May;72(5):1308-14. doi: 10.1086/375121. Epub 2003 Apr 10.
7
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
Am J Hum Genet. 2003 May;72(5):1117-30. doi: 10.1086/375033. Epub 2003 Apr 3.
8
Modifiers of risk of hereditary breast and ovarian cancer.
Nat Rev Cancer. 2002 Feb;2(2):113-23. doi: 10.1038/nrc726.
9
Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist.
J Clin Oncol. 2003 Feb 15;21(4):740-53. doi: 10.1200/JCO.2003.05.096.
10
Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.
Cancer Control. 2002 Nov-Dec;9(6):457-65. doi: 10.1177/107327480200900602.
Zotero 插件